CORTINOVIS DIEGO LUIGI

Malapelle, U., Passiglia, F., Pepe, F., Pisapia, P., Lucia Reale, M., Cortinovis, D., et al. (2024). The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database. LUNG CANCER, 191(May 2024) [10.1016/j.lungcan.2024.107787]. Dettaglio

Leonetti, A., Perrone, F., Puntoni, M., Maglietta, G., Bordi, P., Bria, E., et al. (2024). Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed. EUROPEAN JOURNAL OF CANCER, 202 [10.1016/j.ejca.2024.114006]. Dettaglio

Szlosarek, P., Creelan, B., Sarkodie, T., Nolan, L., Taylor, P., Olevsky, O., et al. (2024). Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma. JAMA ONCOLOGY [10.1001/jamaoncol.2023.6789]. Dettaglio

Passiglia, F., Lucia Reale, M., Lo Russo, G., Pasello, G., Minuti, G., Bulotta, A., et al. (2024). Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program. LUNG CANCER, 187(January 2024) [10.1016/j.lungcan.2023.107444]. Dettaglio

Villa, M., Malighetti, F., Sala, E., Sharma, G., Arosio, G., Gemelli, M., et al. (2024). New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients. NPJ PRECISION ONCOLOGY, 8(1) [10.1038/s41698-024-00498-w]. Dettaglio